KRAS and pancreatic adenocarcinoma: To establish directly comparable lung and liver PDAC metastasis, we utilized a murine pancreatic adenocarcinoma cell line driven by Kras and Trp53 mutations (KPC) [12] injected into the two most common visceral sites of metastatic disease, liver, and lung.